Member Info for VikR

When an ODD gets granted it adds a premium to the drug before anything even needs to happen including

Market exclusivity

Tax credits

Grants

What NFX was before to what it is now cannot be compared. Doubters were here pre FDA approval, and the message was then unequivocally this is going to get granted. Now the skeptics are questioning a deal conclusion. It is no longer if a deal is announced it is a question of when and by how much.

New investors please read the historical clinical trial data which was requested by Pharma and yielded phenomenal results on human lung tissue. This will secure a deal and it will happen sooner rather than later.

Even a small deal propels the share price to at least 5-10 fold, risk to reward favours the latter considerably.

Anyway I’m not here to convince the masses I’ve placed my funds here and have many millions of shares here with £20k put in today alone, won’t top slice until deal concluded

While we await this to move up check out NFX, second ODD approval by the FDA today and a licensing deal imminent. Small market cap that can ten fold on the next news.

SVNSs turn will come in due course but if you seek short term rewards check it out

The upside here is huge. I only came across NFX a few months ago and I thought it was another speculative play. However when I started reading the back story and going through the clinical trial data gathered thus far I soon realised this is not another ‘what if scenario’’. The product has yielded some of the best results ever seen in the lung slicing studies and the prognostic markers of disease activity have reduced with the NXP002 dramatically. I have already mentioned that inhaled route is always a lot safer then oral administration. We know the drug is already licensed for oral administration therefore the clinical trials will be a lot simpler and cost effective with a change of route in administration. Before being given ODD, the FDA look at a lot of factors and will have independently verified the mode of action and looked at the accompanying data. FDA look at the application holistically before granting the designation and we know it is not done lightly.

I got it right last time with IMM and rode that from 3-4p upto 19.5p. I have a strong feeling the same thing will happen here so astute investors you’re either in or out.

However there is no case for de ramping now. NFX is in the most strongest position it has ever been in a long time.

Load and load and load

Check out NFX for anyone interested in Pharma plays. Similar price to here but just been granted second ODD by the FDA. Transformational news and licensing deal pending on its flagship evidenced based proven product

Take whatever money you have left and put it in NFX, they have just been given ODD for the second time by FDA, hugely undervalued share with massive upside and a product actually worth commercializing. I have put 20k in there today so far

15k topped up so far

A bargain at these levels

Expecting 0.5p to be taken out in the next few sessions

Orphan drug designation granted by the FDA on NXP002 could make the next big move up just like IMM did back in September 2025. In a very similar position to IMM now and waiting for a licensing agreement although IMM has a lot more clinical trial data to hand.

Both best pharma buys for 2026 and one to have on your list.

The pieces of the jigsaw are coming together.

I am beginning to load heavy now on any dips.

Persevering with the FDA and the numerous emails sent by everyone pushed them into action. This is a very important big deal and this will now make a similar move to IMM which went from 3-4p upto 19p intraday last September.

Not one but x 2 lots of orphan drug designations. The scientists on here will know the extreme importance of such a critical component to negotiations. NFX now has the upper hand at the table and can dictate favorable terms to progress NXP002 forward.

This is absolutely transformative news and needs to be shared from the rooftops

Strong buy from me and il be topping up throughout the day

Positive news incoming

This is what happens when the MC had already priced everything in, it has to come down during times of turbulence. Jan is holding well and even MILA is on the up, I think this could continue to fall until we agree ceasefire and the wider macreconomics calm down. I know holders who have purchased higher up do not want to hear this, but the charts tell there own story

This zone is soon going to get exhausted and the MMs will have to eventually tick it up. Holders are now accumulating and not selling and we get closer to further assay results continuously. I project it will make a quick move to 0.30 + very soon.

80 M was an already an excellent buy has just got even more compelling. The message is being spread on US news outlets of the Jameson land drilling far and wide. I will look to add next week as this will be moving up this month in quick succession. This is one move I do not want to be out of, even if the MMs take this back down pre 1p and try to create a false narrative in the short term.

I will have to slice some other holdings to be bring funds into here asap

Strong buy from me

Finally published my buy from this week

Fully locked and loaded and the chart is looking good for a move up as per this weeks chart analysis:

https://x.com/breakoutcv/status/2030293755874484730?s=46

It’s going to be a pivotal week on the announcement of world leading assay results. All pointing to a spectacular find and take your pick from not one but two flagship projects.

Yes you are absolutely correct

Looking at historical events of 2011 we could see history repeating itself. Let alone actually mining the gold the events leading up to it with an increasing gold price will send this parabolic. Imagine seeing 35-40p having purchased around 2.5p, you only need one JAN in your portfolio to change your life forever

Money going into JAN with news to drop at

any moment on what could be world class assays. Meanwhile this is close to my pre 20p target buy in price

I’m in both JAN and WSBN, I have around £30k in here of which I am around 8k in the red. JAN however is around 40k in the blue but I will not sell a single share there. Pretty soon it could be in double figures.

WSBN is speculative for me but hope it works out as if the news is poor I can imagine my 30k turns to 3k pretty swiftly.

No news is good news until otherwise so remain optimistic for now

I think the demand is strong I just posted on my X market makers will take 40k in one go just now, this is always a good sign and illustrates solid consistent demand. I always get paranoid that while taking the screenshot I hope I don’t accidentally press the sell button, real life problems haha

I agree safe haven

- JAN

- ORR

—ORCP

Best gold plays for 2026 and now ever more pertinent then before.

All steady here pre news

This and JAN my best 2 gold exploration investments of 2026 with proven in situ resources. Safe haven for big funds to be parked while we await a substantive re rate